Ningxia Qiyuan Pharma
About
Company description
Ningxia Qiyuan Pharmaceutical Co., Ltd. was established in January 2001, by the former state-owned enterprise Ningxia Pharmaceutical Factory and Ningxia Traditional Chinese Medicine Factory. The company adheres to the inheritance and seizes the opportunity. After nearly two decades of unremitting efforts, the company has now developed into a modern large-scale comprehensive biopharmaceutical enterprise well-known at home and abroad,
The company relies on Ningxia's regional advantages suitable for the development of biopharmaceuticals, and vigorously develops the development and production of antibiotic raw materials, vitamin raw materials, and deep processing of corn. The company's tetracycline API series products are exclusive products in the world. Erythromycin API and its synthetic products are currently one of the world's three largest suppliers. Vitamin C series products occupy a place in the domestic and foreign markets due to their scale and quality.
The company pays attention to product quality and product research and development, and is listed as a national high-tech enterprise. The company's technology center is a national enterprise technology center. Erythromycin and tetracycline hydrochloride raw materials have passed the US FDA, European COS and EUGMP certification, as well as official quality audits in India, Japan and other countries. The company's vitamin C products have passed international food certifications, such as HALAL, KOSHER, etc. The company's products are sold in dozens of countries and regions in Europe, South America, Africa, Southeast Asia and so on. The company's "Qiyuan" registered trademark has been recognized as "Ningxia Famous Trademark" by the Ningxia Hui Autonomous Region Administration for Industry and Commerce many times.
